Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas

[1]  R. Hawkins,et al.  Diabetes matters in primary care , 2002, International Journal of Integrated Care.

[2]  D. Easton,et al.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. , 1993, American journal of human genetics.

[3]  J. Weber,et al.  Closing in on a breast cancer gene on chromosome 17q. , 1992, American journal of human genetics.

[4]  Barry F. Smith,et al.  Loss of NF1 alleles in phaeochromocytomas from patients with type 1 neurofibromatosis , 1992, Genes, chromosomes & cancer.

[5]  S. Friend,et al.  Screening for germ line TP53 mutations in breast cancer patients. , 1992, Cancer research.

[6]  B. Vogelstein,et al.  Inherited p53 gene mutations in breast cancer. , 1992, Cancer research.

[7]  R. Cawthon,et al.  Somatic mutations in the neurofibromatosis 1 gene in human tumors , 1992, Cell.

[8]  H. J. Evans,et al.  Constitutional p53 mutation in a non-Li-Fraumeni cancer family. , 1992, British Journal of Cancer.

[9]  J. Nesland,et al.  Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas , 1992, Genes, chromosomes & cancer.

[10]  M. Rocchi,et al.  The nm23 gene maps to human chromosome band 17q22 and shows a restriction fragment length polymorphism with bg/II , 1992, Genes, chromosomes & cancer.

[11]  Thierry Soussi,et al.  TP53 tumor suppressor gene: A model for investigating human mutagenesis , 1992, Genes, chromosomes & cancer.

[12]  S. Friend,et al.  Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P L Pearson,et al.  Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. , 1991, Oncogene.

[14]  G. Lenoir,et al.  Familial breast-ovarian cancer locus on chromosome 17q12-q23 , 1991, The Lancet.

[15]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[16]  H. J. Evans,et al.  Mutations in p53 do not account for heritable breast cancer: a study in five affected families. , 1991, British Journal of Cancer.

[17]  M. King,et al.  Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.

[18]  W. Blattner,et al.  Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome , 1990, Nature.

[19]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[20]  A. Tanigami,et al.  Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. , 1990, Cancer research.

[21]  R. Lidereau,et al.  Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Nesland,et al.  Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis. , 1990, British Journal of Cancer.

[23]  C. M. Steel,et al.  Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis , 1990, The Lancet.

[24]  C. Larsson,et al.  Genomic alterations in human breast carcinomas , 1990, Genes, chromosomes & cancer.

[25]  K. Kidd,et al.  Report of the DNA committee and catalogues of cloned and mapped genes and DNA polymorphisms. , 1990, Cytogenetics and cell genetics.

[26]  H. J. Evans,et al.  p53 gene mRNA expression and chromosome 17p allele loss in breast cancer. , 1990, British Journal of Cancer.

[27]  P. Devilee,et al.  Loss of heterozygosity on 17p in human breast carcinomas: defining the smallest common region of deletion. , 1990, Cytogenetics and cell genetics.

[28]  D. Slamon.  Studies of the HER-2/neu proto-oncogene in human breast cancer. , 1990, Cancer investigation.

[29]  H. Lynch,et al.  Epidemiology and Risk Factors , 1989, Clinical obstetrics and gynecology.

[30]  E. E. Gresch.  Genetic Alterations During Colorectal-Tumor Development , 1989 .

[31]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.

[32]  U. Bergerheim,et al.  Deletion mapping in human renal cell carcinoma. , 1989, Cancer research.

[33]  A. Forrest,et al.  ALLELE LOSS ON SHORT ARM OF CHROMOSOME 17 IN BREAST CANCERS , 1988, The Lancet.

[34]  P. L. Chen,et al.  Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. , 1988, Science.

[35]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[36]  J. Haines,et al.  Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma , 1988, Nature.

[37]  C. Larsson,et al.  Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma , 1988, Nature.

[38]  J. Haines,et al.  Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22 , 1987, Nature.

[39]  P. S. St George-Hyslop,et al.  Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis. , 1987, Science.

[40]  H. Brauch,et al.  Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma , 1988, Nature.

[41]  B. Gallie,et al.  Genetic origin of mutations predisposing to retinoblastoma. , 1985, Science.

[42]  A. Knudson.  Retinoblastoma: a prototypic hereditary neoplasm. , 1978, Seminars in oncology.

[43]  J. Fraumeni,et al.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? , 1969, Annals of internal medicine.